AR US Versus sUS or Fluoroscopic Injections for Shoulder Punction

Sponsor
Balgrist University Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06053892
Collaborator
(none)
100
3
39

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to prospectively evaluate the potential benefits of injections with Augmented Reality enhanced Ulrasound versus standard Ultrasound or fluoroscopy participants where assigend for fluoroscopic joint injections oder for Ultrasound guided injection.

The main question[s] it aims to answer are:
  • The primary objective is to evaluate the duration of the different interventions

  • the count of needle passes

  • assess the reduction of radiation exposure using AR US rather than fluoroscopic guidance for joint injections

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Puncture
N/A

Detailed Description

Patients assigned for standard Ultrasound or fluoroscopic joint injection are informed about the trial. Participants are randomly assigned to the study or control intervention. 1:1 randomization is used.

In both groups, data on duration of the intervention, count of needle passes, correctness of injection location and radiation exposure will be collected. The outcome measures will be compared between the groups.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Masking Description:
The assignment into the study groups is going to be performed by 1:1 randomization using randomisation cards which are drawn by author-ised study staff.
Primary Purpose:
Diagnostic
Official Title:
Comparison of Time for Prucedure, and Effectiveness Between Augmented Reality Enhanced Ultrasound-guided Versus Standard Ultrasound or Fluoroscopic Injections
Anticipated Study Start Date :
Sep 30, 2023
Anticipated Primary Completion Date :
Dec 31, 2025
Anticipated Study Completion Date :
Dec 31, 2026

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: AR US

Augmented reality sonography guidance for shoulder punctures

Diagnostic Test: Puncture
Shoulder puncture with the newly designed technique using AR to overlie the US image to the imaged anatomical structures in comparision to standard US and flurosopic-guidance.

Active Comparator: standard US

standard sonography guidance for shoulder punctures

Diagnostic Test: Puncture
Shoulder puncture with the newly designed technique using AR to overlie the US image to the imaged anatomical structures in comparision to standard US and flurosopic-guidance.

Active Comparator: Fluoroscopic

Fluroscopic guidance for shoulder punctures

Diagnostic Test: Puncture
Shoulder puncture with the newly designed technique using AR to overlie the US image to the imaged anatomical structures in comparision to standard US and flurosopic-guidance.

Outcome Measures

Primary Outcome Measures

  1. Augmented reality sonography is less time consuming [10 minutes]

    Puncturing shoulders with Augmented reality sonography is faster (measuring the time in minutes and seconds) than when using standard sonography- from point of entry the skin until the target

Secondary Outcome Measures

  1. Sonography is more efficient than fluoroscopic- guidance in shoulder puncturing [10 minutes (ml aspirated) to 3 days (laboratory results)]

    More fluid (measured in ml) can be aspirated with lower false negative results (laboratory results) when puncutring shoulders with US-guidance in comparison to fluoroscopic guidance

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
    • Patients 18 to 99 years of age
  • Patients assigned for fluoroscopic guided injections (including MR arthrographies)

  • Patients assigned for US guided injections (including MR arthrographies)

Exclusion Criteria:
    • Patients who are not willing to be part of the study
  • Contraindication against fluoroscopic guided injection

  • Women who are pregnant or breast feeding (Pregnancy assessment is part of the routine prior to fluoroscopic joint injections. No pregnancy test will be done for this study.)

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Balgrist University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Balgrist University Hospital
ClinicalTrials.gov Identifier:
NCT06053892
Other Study ID Numbers:
  • R471
First Posted:
Sep 26, 2023
Last Update Posted:
Sep 26, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Sep 26, 2023